Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections

hattip Yaya

Let’s help the very sharp students out at Queen’s U.

Remove Vaccine Mandate for Queen’s University

Is it obvious enough yet? This is a business model. This is the business model. Because this is very big exploitative crony capitalist business!

As I’d previously written- not accessible via the wayback, sorry

The link outwards regarding ADE possibility takes you here



Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and dengue virus vaccine studies revealed human clinical safety risks related to ADE, resulting in failed vaccine trials.

From earlier today:

Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

Wise Words
Hellequin, Gentleman Bastard

The Pharmaceutical Industry is just as interested in World Health as the Arms Industry is in World Peace.
Anyone who hasn’t grasped that by now cannot be helped any more.

8 replies on “Mass Market Model: ADE’s, Leaky Vaccines and Breakthrough Infections”

Leave a Reply